[Determination of growth hormone in plasma of psoriatic arthritis, psoriasis vulgaris and seronegative spondylarthritis].
By means of radio-immunoassay the concentration of human growth hormone (HGH) was measured in the blood plasma of 61 patients with psoriasis (21 suffering from psoriasis vulgaris and 40 with psoriatic arthritis), 30 patients with ankylosing spondylitis, 9 with atypical spondylarthritis and 34 patients with diseases of the soft tissue or degenerative joint and spinal column disease. No connection was found between the HGH concentration and the skin lesions in psoriasis. On the other hand a correlation between HGH and the sacroiliitis in psoriatic arthritis and seronegative spondyloarthropathies may be possible. In contrast to the plasma of psoriatics, the mean HGH concentration was higher in the plasma of patients with degenerative joint diseases. Therefore the results of this paper confirm those opinions in the literature which deny increased HGH concentrations in psoriatics. The beneficial effect of the therapeutic administration of somatostatin, an inhibitor of the release of HGH, in psoriasis vulgaris and psoriatic arthritis is - if indeed it occurs - attributable to other hitherto unidentified mechanisms.
Partsch
G
G
Schwarzer
C
C
Dunky
A
A
Mayer
F
F
Gschnait
F
F
Neumüller
J
J
Eberl
R
R
D000328:Adult; D001168:Arthritis / Q000097:blood*; D005260:Female; D013006:Growth Hormone / Q000097:blood*; D006801:Humans; D066298:In Vitro Techniques; D007592:Joint Diseases / Q000097:blood; D008875:Middle Aged; D011565:Psoriasis / Q000097:blood* / Q000188:drug therapy; D011863:Radioimmunoassay / Q000379:methods; D013004:Somatostatin / Q000627:therapeutic use; D013167:Spondylitis, Ankylosing / Q000097:blood*
D013004:Somatostatin; D013006:Growth Hormone
Wachstumshormonbestimmung im Plasma bei Arthritis psoriatica, Psoriasis vulgaris und seronegativen Spondarthritiden.